Background: Some clinicians link chronic disease in certain patients to 'food intolerance'. This is currently diagnosed by exclusion dieting, a time-consuming and tedious technique. It has been claimed that IgE/IgG4 antibody testing is a rapid and valid method of determining food intolerance.
Objective: To determine the test/retest reliability of IgE/IgG4 antibody testing as a diagnostic tool.
Methods: Blinded testing of duplicate blood samples from nine patients with suspected food intolerance was undertaken by tertiary referral centre using the services of a commercial laboratory. The proportions of consistent and inconsistent results for tests of 95 different foods were analysed.
Results: Test/retest reliability was low. Even though the study method systematically overestimated kappa, this value never exceeded 0.51, regardless of the statistical model used. All but one patient had a greater number of inconsistent results than had been prespecified as an unacceptable level of disagreement. In one case, 50 out of 95 test results were inconsistent on retest.
Conclusions: We found no evidence that IgE/IgG4 antibody testing as performed by this laboratory is a reliable diagnostic tool.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1365-2222.1998.00367.x | DOI Listing |
Emerg Microbes Infect
December 2024
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.
J Allergy Clin Immunol
November 2024
Division of Allergy and Immunology, Department of Pediatrics, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:
Background: The bead-based epitope assay has been used to identify epitope-specific (es) antibodies and successfully used to diagnose clinical allergy to milk, egg, and peanut.
Objective: We sought to identify es-IgE, es-IgG4, and es-IgG1 of wheat proteins and determine the optimal peptides to differentiate wheat-allergic from wheat-tolerant using the bead-based epitope assay.
Methods: Children and adolescents who underwent an oral food challenge to confirm their wheat allergy status were enrolled.
Curr Allergy Asthma Rep
September 2024
Center for Biologics Evaluation and Research, US Food and Drug Administration, 10309 New Hampshire Avenue Building 52, Room 3332, Silver Spring, MD, USA.
Purpose Of Review: Allergenic extracts are often standardized to control for potency, either by measuring concentrations of major allergens or "overall allergenicity" by competition for IgE in pooled sera from highly allergic subjects with a reference extract. Recent developments present an opportunity to use human mAb cloned from highly allergic subjects to define potency of allergenic extracts.
Recent Findings: Two recent developments present an opportunity for revising potency measurements of allergen extracts: cloning allergen specific IgE from allergic subjects and extensive epitope mapping of major allergenic proteins.
Int Immunopharmacol
March 2024
Departamento de Microbiología y Parasitología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
The phenotype of allergic diseases associated with Anisakis determines the pattern of cytokines related to antibody production. However, the role of serum IgA and the immunomodulatory mechanisms exerted by active infection of L3 or passive mucosal contact with A. simplex specific antigens has not been studied before.
View Article and Find Full Text PDFBiology (Basel)
October 2023
Institute for Immunological Research, University of Cartagena, Cartagena de Indias 130012, Colombia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!